2025 Merkin Prize in Biomedical Technology: CAR T-cell Therapy @broadinstitute

Uploaded September 2025 | Updated September 2026, 2 weeks ago

Four biomedical innovators — Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain — have been jointly awarded the 2025 Richard N. Merkin Prize in Biomedical Technology for developing chimeric antigen receptor (CAR) T-cell therapy, a groundbreaking form of personalized cancer immunotherapy that turns T cells into tumor killers and has led to durable remissions in tens of thousands of patients with previously incurable blood cancers.

For more information, visit merkinprize.org

broadinstitute.org

Copyright Broad Institute, 2025. All rights reserved.

2025 Merkin Prize in Biomedical Technology: CAR T-cell Therapy

Ladders to Cures Accelerator Symposium: Next Generation Scalable Technology

Machine Learning in Drug Discovery Symposium: Closing Remarks

ML4H: E. Oikonomou/R. Khera, Personalized Inference from Randomized Clinical Trials to Real Care

MPG Primer: Local ancestry inference (LAI) (2026)

MPG Primer: Genotype, Phenotype, and GWAS Data (2026)

ML4H: Milos Vukadinovic, Vision-language Foundation Models for Cardiac Imaging

Machine Learning in Drug Discovery: Oren Kraus

11th Annual Rare Disease Day Event: Scientific Keynote, Mandana Arbab

Three Impactful problems in drug discovery that might be solvable with machine learning

MIA Primer: Jacob Blindenbach, Ultra-secure computing with homomorphic encryption for genome privacy

MPG Primer: DNA sequencing with the Blended Genome Exome (2025)